{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:54:47Z","timestamp":1793969687176,"version":"4.8.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-024-03298-3","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T10:02:34Z","timestamp":1727431354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk factors of uterine perforation when using contraceptive intrauterine devices"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8767-6764","authenticated-orcid":false,"given":"Fatemeh","family":"Tabatabaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Tala Nabipour","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Hakimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Vejdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"3298_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.contraception.2014.08.011","volume":"91","author":"J Trussell","year":"2015","unstructured":"Trussell J, Hassan F, Lowin J, Law A, Filonenko A. Achieving cost-neutrality with long-acting reversible contraceptive methods. Contraception. 2015;91:49\u201356. https:\/\/doi.org\/10.1016\/j.contraception.2014.08.011. PubMed PMID: 25282161; PubMed Central PMCID: PMCPMC4268022.","journal-title":"Contraception"},{"key":"3298_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.contraception.2015.01.007","volume":"91","author":"K Heinemann","year":"2015","unstructured":"Heinemann K, Reed S, Moehner S, Minh TD. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European active surveillance study on Intrauterine devices. Contraception. 2015;91:274\u20139. https:\/\/doi.org\/10.1016\/j.contraception.2015.01.007. PubMed PMID: 25601352.","journal-title":"Contraception"},{"key":"3298_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.contraception.2010.06.006","volume":"82","author":"RA Lewis","year":"2010","unstructured":"Lewis RA, Taylor D, Natavio MF, Melamed A, Felix J, Mishell D Jr. Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability. Contraception. 2010;82:491\u20136. PubMed PMID: 21074010.","journal-title":"Contraception"},{"key":"3298_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/13625187.2018.1535653","volume":"23","author":"A Agostini","year":"2018","unstructured":"Agostini A, Godard C, Laurendeau C, Benmahmoud Zoubir A, Lafuma A, L\u00e9vy-Bachelot L, et al. Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database. Eur J Contracept Reprod Health Care. 2018;23:421\u20136. PubMed PMID: 30499732.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"3298_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.contraception.2016.10.006","volume":"95","author":"TC Jatlaoui","year":"2017","unstructured":"Jatlaoui TC, Riley HEM, Curtis KM. The safety of intrauterine devices among young women: a systematic review. Contraception. 2017;95:17\u201339. https:\/\/doi.org\/10.1016\/j.contraception.2016.10.006. PubMed PMID: 27771475; PubMed Central PMCID: PMCPMC6511984.","journal-title":"Contraception"},{"key":"3298_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/aog.0000000000000144","volume":"123","author":"J Aoun","year":"2014","unstructured":"Aoun J, Dines VA, Stovall DW, Mete M, Nelson CB, Gomez-Lobo V. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol. 2014;123:585\u201392. https:\/\/doi.org\/10.1097\/aog.0000000000000144. PubMed PMID: 24499755.","journal-title":"Obstet Gynecol"},{"key":"3298_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1089\/jwh.2015.5190","volume":"24","author":"NE Birgisson","year":"2015","unstructured":"Birgisson NE, Zhao Q, Secura GM, Madden T, Peipert JF. Positive testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the risk of pelvic inflammatory disease in IUD users. J Womens Health (Larchmt). 2015;24:354\u20139. https:\/\/doi.org\/10.1089\/jwh.2015.5190. PubMed PMID: 25836384; PubMed Central PMCID: PMCPMC4440993.","journal-title":"J Womens Health (Larchmt)"},{"key":"3298_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.contraception.2016.07.006","volume":"94","author":"EN Berry-Bibee","year":"2016","unstructured":"Berry-Bibee EN, Tepper NK, Jatlaoui TC, Whiteman MK, Jamieson DJ, Curtis KM. The safety of intrauterine devices in breastfeeding women: a systematic review. Contraception. 2016;94:725\u201338. https:\/\/doi.org\/10.1016\/j.contraception.2016.07.006. PubMed PMID: 27421765.","journal-title":"Contraception"},{"key":"3298_CR9","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1093\/humrep\/des246","volume":"27","author":"J Kaislasuo","year":"2012","unstructured":"Kaislasuo J, Suhonen S, Gissler M, L\u00e4hteenm\u00e4ki P, Heikinheimo O. Intrauterine contraception: incidence and factors associated with uterine perforation\u2013a population-based study. Hum Reprod. 2012;27:2658\u201363. https:\/\/doi.org\/10.1093\/humrep\/des246. PubMed PMID: 22763376.","journal-title":"Hum Reprod"},{"key":"3298_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/aog.0000000000002822","volume":"132","author":"TC Jatlaoui","year":"2018","unstructured":"Jatlaoui TC, Whiteman MK, Jeng G, Tepper NK, Berry-Bibee E, Jamieson DJ, et al. Intrauterine device Expulsion after Postpartum Placement: a systematic review and Meta-analysis. Obstet Gynecol. 2018;132:895\u2013905. https:\/\/doi.org\/10.1097\/aog.0000000000002822. PubMed PMID: 30204688; PubMed Central PMCID: PMCPMC6549490.","journal-title":"Obstet Gynecol"},{"key":"3298_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.contraception.2019.04.011","volume":"100","author":"EK Hinz","year":"2019","unstructured":"Hinz EK, Murthy A, Wang B, Ryan N, Ades V. A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device. Contraception. 2019;100:101\u20135. https:\/\/doi.org\/10.1016\/j.contraception.2019.04.011. PubMed PMID: 31108053.","journal-title":"Contraception"},{"key":"3298_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.05.032","author":"EP Gurney","year":"2018","unstructured":"Gurney EP, Sonalkar S, McAllister A, Sammel MD, Schreiber CA. Six-month expulsion of postplacental copper intrauterine devices placed after vaginal delivery. Am J Obstet Gynecol. 2018;219. https:\/\/doi.org\/10.1016\/j.ajog.2018.05.032. PubMed PMID: 29870737; PubMed Central PMCID: PMCPMC6125156. :183.e1-.e9."},{"key":"3298_CR13","doi-asserted-by":"crossref","unstructured":"Rowe P, Farley T, Peregoudov A, Piaggio G, Boccard S, Landoulsi S et al. Corrigendum to Rowe P safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A [Contraception. 2016;93:498\u2013506]. Contraception. 2016;94:288. doi: 10.1016\/j.contraception.2016.06.001. PubMed PMID: 27312266; PubMed Central PMCID: PMCPMC5357721.","DOI":"10.1016\/j.contraception.2016.06.001"},{"key":"3298_CR14","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/AOG.0b013e3181f73fac","volume":"116","author":"BA Chen","year":"2010","unstructured":"Chen BA, Reeves MF, Hayes JL, Hohmann HL, Perriera LK, Creinin MD. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial. Obstet Gynecol. 2010;116:1079\u201387. https:\/\/doi.org\/10.1097\/AOG.0b013e3181f73fac. PubMed PMID: 20966692; PubMed Central PMCID: PMCPMC3104850.","journal-title":"Obstet Gynecol"},{"key":"3298_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.contraception.2015.12.006","volume":"93","author":"MK Baldwin","year":"2016","unstructured":"Baldwin MK, Edelman AB, Lim JY, Nichols MD, Bednarek PH, Jensen JT. Intrauterine device placement at 3 versus 6 weeks postpartum: a randomized trial. Contraception. 2016;93:356\u201363. .006. PubMed PMID: 26686914.","journal-title":"Contraception"},{"key":"3298_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.contraception.2017.03.007","volume":"95","author":"K Heinemann","year":"2017","unstructured":"Heinemann K, Barnett C, Reed S, M\u00f6hner S, Do Minh T. IUD use among parous women and risk of uterine perforation: a secondary analysis. Contraception. 2017;95:605\u20137. https:\/\/doi.org\/10.1016\/j.contraception.2017.03.007. PubMed PMID: 28322770.","journal-title":"Contraception"},{"key":"3298_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","volume":"65","author":"KM Curtis","year":"2016","unstructured":"Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65:1\u2013103. https:\/\/doi.org\/10.15585\/mmwr.rr6503a1. PubMed PMID: 27467196.","journal-title":"MMWR Recomm Rep"},{"key":"3298_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jmig.2015.08","volume":"23","author":"AM Eskew","year":"2016","unstructured":"Eskew AM, Crane EK. Levonorgestrel Intrauterine Device Placement in a premenopausal breast Cancer patient with a Bicornuate Uterus. J Minim Invasive Gynecol. 2016;23:133\u20135. https:\/\/doi.org\/10.1016\/j.jmig.2015.08. .888. PubMed PMID: 26342448.","journal-title":"J Minim Invasive Gynecol"},{"key":"3298_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.contraception.2010.02.011","volume":"82","author":"LB Zapata","year":"2010","unstructured":"Zapata LB, Whiteman MK, Tepper NK, Jamieson DJ, Marchbanks PA, Curtis KM. Intrauterine device use among women with uterine fibroids: a systematic review. Contraception. 2010;82:41\u201355. PubMed PMID: 20682142.","journal-title":"Contraception"},{"key":"3298_CR20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jmig.2013.12.123","volume":"21","author":"KA Kho","year":"2014","unstructured":"Kho KA, Chamsy DJ. Perforated intraperitoneal intrauterine contraceptive devices: diagnosis, management, and clinical outcomes. J Minim Invasive Gynecol. 2014;21:596\u2013601. https:\/\/doi.org\/10.1016\/j.jmig.2013.12.123. PubMed PMID: 24462588; PubMed Central PMCID: PMCPMC6661232.","journal-title":"J Minim Invasive Gynecol"},{"key":"3298_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/oajc.s85546","volume":"7","author":"S Rowlands","year":"2016","unstructured":"Rowlands S, Oloto E, Horwell DH. Intrauterine devices and risk of uterine perforation: current perspectives. Open Access J Contracept. 2016;7:19\u201332. https:\/\/doi.org\/10.2147\/oajc.s85546. PubMed PMID: 29386934; PubMed Central PMCID: PMCPMC5683155.","journal-title":"Open Access J Contracept"},{"key":"3298_CR22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.7863\/jum.2010.29.10.1453","volume":"29","author":"TD Shipp","year":"2010","unstructured":"Shipp TD, Bromley B, Benacerraf BR. The width of the uterine cavity is narrower in patients with an embedded intrauterine device (IUD) compared to a normally positioned IUD. J Ultrasound Med. 2010;29:1453\u20136. https:\/\/doi.org\/10.7863\/jum.2010.29.10.1453. PubMed PMID: 20876899.","journal-title":"J Ultrasound Med"},{"key":"3298_CR23","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1097\/aog.0000000000001644","volume":"128","author":"Committee Opinion 672","year":"2016","unstructured":"Committee Opinion 672. Clinical challenges of Long-Acting Reversible Contraceptive methods. Obstet Gynecol. 2016;128:e69\u201377. https:\/\/doi.org\/10.1097\/aog.0000000000001644. PubMed PMID: 27548557.","journal-title":"Obstet Gynecol"},{"key":"3298_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/13625187.2021.1874337","volume":"26","author":"F Tabatabaei","year":"2021","unstructured":"Tabatabaei F, Masoumzadeh M. Dislocated intrauterine devices: clinical presentations, diagnosis and management. Eur J Contracept Reprod Health Care. 2021;26:160\u20136. https:\/\/doi.org\/10.1080\/13625187.2021.1874337. PubMed PMID: 33555216.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"3298_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.contraception.2016.10.011","volume":"95","author":"AM Abbas","year":"2017","unstructured":"Abbas AM, Abdellah MS, Khalaf M, Bahloul M, Abdellah NH, Ali MK, et al. Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: a randomized double-blind controlled trial. Contraception. 2017;95:251\u20136. https:\/\/doi.org\/10.1016\/j.contraception.2016.10.011. PubMed PMID: 27823944.","journal-title":"Contraception"},{"key":"3298_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/aog.0000000000001596","volume":"128","author":"RB Rapkin","year":"2016","unstructured":"Rapkin RB, Achilles SL, Schwarz EB, Meyn L, Cremer M, Boraas CM, et al. Self-administered lidocaine gel for Intrauterine device insertion in Nulliparous women: a Randomized Controlled Trial. Obstet Gynecol. 2016;128:621\u20138. https:\/\/doi.org\/10.1097\/aog.0000000000001596. PubMed PMID: 27500351.","journal-title":"Obstet Gynecol"},{"key":"3298_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3109\/13625187.2010.514081","volume":"15","author":"K Blanas","year":"2010","unstructured":"Blanas K, Theodora M, Hassanaien M. Incidental discovery of two levonorgestrel-releasing intrauterine systems misplaced in the peritoneal cavity. Eur J Contracept Reprod Health Care. 2010;15:441\u20134. PubMed PMID: 20874084.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"3298_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ijgo.12130","volume":"137","author":"J Melo","year":"2017","unstructured":"Melo J, Tschann M, Soon R, Kuwahara M, Kaneshiro B. Women\u2019s willingness and ability to feel the strings of their intrauterine device. Int J Gynaecol Obstet. 2017;137:309\u201313. https:\/\/doi.org\/10.1002\/ijgo.12130. PubMed PMID: 28218963; PubMed Central PMCID: PMCPMC5584634.","journal-title":"Int J Gynaecol Obstet"},{"key":"3298_CR29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ogc.2015.07.004","volume":"42","author":"E Friedlander","year":"2015","unstructured":"Friedlander E, Kaneshiro B. Therapeutic options for unscheduled bleeding Associated with Long-Acting Reversible Contraception. Obstet Gynecol Clin North Am. 2015;42:593\u2013603. 004. PubMed PMID: 26598302.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"3298_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.07.025","author":"JT Diedrich","year":"2015","unstructured":"Diedrich JT, Desai S, Zhao Q, Secura G, Madden T, Peipert JF. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. Am J Obstet Gynecol. 2015;212. https:\/\/doi.org\/10.1016\/j.ajog.2014.07.025. PubMed PMID: 25046805; PubMed Central PMCID: PMCPMC4275360. :50.e1-8."},{"key":"3298_CR31","doi-asserted-by":"publisher","first-page":"e0147029","DOI":"10.1371\/journal.pone.0147029","volume":"11","author":"E Roura","year":"2016","unstructured":"Roura E, Travier N, Waterboer T, de Sanjos\u00e9 S, Bosch FX, Pawlita M, et al. The influence of hormonal factors on the risk of developing Cervical Cancer and Pre-cancer: results from the EPIC Cohort. PLoS ONE. 2016;11:e0147029. https:\/\/doi.org\/10.1371\/journal.pone.0147029. PubMed PMID: 26808155; PubMed Central PMCID: PMCPMC4726518.","journal-title":"PLoS ONE"},{"key":"3298_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijgo.2010.10.013","volume":"113","author":"MV Bahamondes","year":"2011","unstructured":"Bahamondes MV, Monteiro I, Canteiro R, Fernandes Ados S, Bahamondes L. Length of the endometrial cavity and intrauterine contraceptive device expulsion. Int J Gynaecol Obstet. 2011;113:50\u20133. PubMed PMID: 21272883.","journal-title":"Int J Gynaecol Obstet"},{"key":"3298_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/uog.6421","volume":"34","author":"BR Benacerraf","year":"2009","unstructured":"Benacerraf BR, Shipp TD, Bromley B. Three-dimensional ultrasound detection of abnormally located intrauterine contraceptive devices which are a source of pelvic pain and abnormal bleeding. Ultrasound Obstet Gynecol. 2009;34:110\u20135. https:\/\/doi.org\/10.1002\/uog.6421. PubMed PMID: 19565532.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3298_CR34","doi-asserted-by":"publisher","unstructured":"Averbach SH, Ma Y, Smith-McCune K, Shiboski S, Moscicki AB. The effect of intrauterine devices on acquisition and clearance of human papillomavirus. Am J Obstet Gynecol. 2017;216:386.e1-.e5. https:\/\/doi.org\/10.1016\/j.ajog.2016.11.1053. PubMed PMID: 27986460; PubMed Central PMCID: PMCPMC5406303.","DOI":"10.1016\/j.ajog.2016.11.1053"},{"key":"3298_CR35","first-page":"602","volume":"55","author":"F Tabatabaei","year":"2017","unstructured":"Tabatabaei F, Tavoli Z. A rare reason of abnormal uterine bleeding. Acta Med Iran. 2017;55:602\u20133. PubMed PMID: 29202556.","journal-title":"Acta Med Iran"},{"key":"3298_CR36","doi-asserted-by":"publisher","unstructured":"Committee Opinion No. 642: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy. Obstet Gynecol. 2015;126:e44-e8. https:\/\/doi.org\/10.1097\/aog.0000000000001106. PubMed PMID: 26393458.","DOI":"10.1097\/aog.0000000000001106"},{"key":"3298_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.contraception.2015.01.011","volume":"91","author":"K Heinemann","year":"2015","unstructured":"Heinemann K, Reed S, Moehner S, Minh TD. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European active surveillance study for Intrauterine devices. Contraception. 2015;91:280\u20133. .011. PubMed PMID: 25601350.","journal-title":"Contraception"},{"key":"3298_CR38","doi-asserted-by":"publisher","unstructured":"ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices. Obstet Gynecol. 2011;118:184\u2009\u2013\u200996. https:\/\/doi.org\/10.1097\/AOG.0b013e318227f05e. PubMed PMID: 21691183.","DOI":"10.1097\/AOG.0b013e318227f05e"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03298-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-024-03298-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03298-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T10:03:23Z","timestamp":1727431403000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-024-03298-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3298"],"URL":"https:\/\/doi.org\/10.1186\/s12905-024-03298-3","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"},{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"31 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from each participant. This study has been approved by the Ethics Committee of the Tabriz University of Medical Sciences, Tabriz, Iran ((IR.TBZMED.REC.1400.686).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"538"}}